BRIEF published on 10/24/2025 at 16:00, 1 year ago The Vanguard Group Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group
BRIEF published on 10/24/2025 at 15:58, 1 year ago The Vanguard Group Discloses Stake in Mural Oncology Ordinary Shares The Vanguard Group Stake Disclosure Mural Oncology Takeover Rules
BRIEF published on 10/24/2025 at 15:57, 1 year ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
PRESS RELEASE published on 10/24/2025 at 15:55, 1 year ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.89% stake in NCC Group plc as of 23 October 2025. Details in compliance with Rule 8.3 of the Takeover Code Takeover Code Vanguard Group Financial Disclosure Stake Disclosure NCC Group Plc
BRIEF published on 10/24/2025 at 15:55, 1 year ago The Vanguard Group Discloses Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
BRIEF published on 10/24/2025 at 15:53, 1 year ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare
PRESS RELEASE published on 10/24/2025 at 15:53, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% stake in Mural Oncology plc as per Form 8.3 with relevant securities details Form 8.3 Relevant Securities The Vanguard Group Stake Disclosure Mural Oncology Plc
BRIEF published on 10/24/2025 at 15:52, 1 year ago The Vanguard Group Discloses Position in Big Yellow Group plc Securities Form 8.3 Disclosure Vanguard Big Yellow
PRESS RELEASE published on 10/24/2025 at 15:52, 1 year ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.04% ownership in JTC plc. Transactions included purchases and sales of 1p ordinary shares Sales Vanguard Group Ownership Disclosure Purchases JTC Plc
BRIEF published on 10/24/2025 at 15:51, 1 year ago Vanguard Group Discloses Stake in Alpha Group International Form 8.3 Takeover Code Securities Disclosure Vanguard Group Alpha Group
Published on 11/10/2026 at 14:45, 5 hours 51 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 6 hours 5 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 6 hours 6 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 6 hours 6 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 6 hours 36 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 18:54, 1 hour 41 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 1 hour 51 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 2 hours 6 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:20, 2 hours 15 minutes ago Edison issues report on Custodian Property Income REIT (LSE: CREI)
Published on 11/10/2026 at 17:31, 3 hours 4 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 6 hours 35 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 9 hours 33 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 13 hours 36 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 2 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
